50 months experience with St-Jude Medical Cardiac Valve Prosthesis
The St. Jude Medical valve has become our mechanical valvular prosthesis of choice because of favorable hemodynamic results that associated with marked clinical improvement and low incidence of thromboembolism.
The data for this study was collected from April 1986 to May 1990, Four years period. There were total of 110 patients(female 53, male 58) in this series with 22 isolated aortic valve, 66 isolated mitral valve, 20 double valve, 2 tricuspid valve
replacement.
The mean follow up time was 23 months.
Postoperatively, 77% of cases were in New York Heart Association(NYHA) functional class I, and mild and moderate symptoms(NYHA II) were present in 20% and there were very few patients remaining in higher functional classifications. In
postoperative
echocardiographic study showed marked improved cardiac function.
The overall early mortality was 5.4% and was higher after double (13.3%) and mitral valve replacement (5.6%) and the late mortality was one case after mitral valve replacement due to endocarditis.
The cause of death in early mortality was attributed to heart failure, acute renal failure, sepsis, etc.
|